Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bone Biologics Corp - warrants
(NQ:
BBLGW
)
10.95
+0.10 (+0.92%)
Streaming Delayed Price
Updated: 2:03 PM EDT, Oct 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
687
Open
10.95
Bid (Size)
8.000 (2)
Ask (Size)
11.00 (2)
Prev. Close
10.85
Today's Range
10.90 - 10.95
52wk Range
10.39 - 95.00
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook
September 04, 2025
From
Bone Biologics Corporation
Via
Business Wire
Bone Biologics to Participate in the H.C. Wainwright Global Investment Conference
September 03, 2025
From
Bone Biologics Corporation
Via
Business Wire
Performance
YTD
-75.3%
-75.3%
1 Month
+0.9%
+0.9%
3 Month
+1.5%
+1.5%
6 Month
-18.9%
-18.9%
1 Year
-65.5%
-65.5%
More News
Read More
Bone Biologics Announces Closing of $5.0 Million Public Offering
June 30, 2025
From
Bone Biologics Corporation
Via
Business Wire
Bone Biologics Announces Pricing of $5.0 Million Public Offering
June 27, 2025
From
Bone Biologics Corporation
Via
Business Wire
Bone Biologics Files Patent Application for Bone Regeneration Technology
June 27, 2025
From
Bone Biologics Corporation
Via
Business Wire
Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements
June 26, 2025
From
Bone Biologics Corporation
Via
Business Wire
Bone Biologics Announces 1-for-6 Reverse Stock Split
June 06, 2025
From
Bone Biologics Corporation
Via
Business Wire
Bone Biologics Appoints Phillip T. Meikle to its Board of Directors
October 21, 2024
From
Bone Biologics
Via
Business Wire
Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds
August 02, 2024
From
Bone Biologics Corporation
Via
Business Wire
First Two Patients Treated in Pilot Clinical Study with Bone Biologics’ NB1 Bone Graft Device in Spine Fusion
June 20, 2024
From
Bone Biologics Corporation
Via
Business Wire
Bone Biologics Executives to be Interviewed in a “CEO Chat” by Zacks Small-Cap Research Analyst on June 20th
June 17, 2024
From
Virtual Investor Conferences
Via
GlobeNewswire
Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors
January 11, 2024
From
Bone Biologics Corporation
Via
Business Wire
Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements
January 10, 2024
From
Bone Biologics Corporation
Via
Business Wire
Bone Biologics Announces 1-for-8 Reverse Stock Split
December 18, 2023
From
Bone Biologics Corporation
Via
Business Wire
Frequently Asked Questions
Is Bone Biologics Corp - warrants publicly traded?
Yes, Bone Biologics Corp - warrants is publicly traded.
What exchange does Bone Biologics Corp - warrants trade on?
Bone Biologics Corp - warrants trades on the Nasdaq Stock Market
What is the ticker symbol for Bone Biologics Corp - warrants?
The ticker symbol for Bone Biologics Corp - warrants is BBLGW on the Nasdaq Stock Market
What is the current price of Bone Biologics Corp - warrants?
The current price of Bone Biologics Corp - warrants is 10.95
When was Bone Biologics Corp - warrants last traded?
The last trade of Bone Biologics Corp - warrants was at 10/31/25 02:03 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.